2nd Quarter - Report

XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)

Firm
Client
Income
—
Expenses
$120,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Issues relating to biodefense and national security strategy, specifically funding for medical countermeasures via the Biomedical Advanced Research and Development Authority (BARDA). Issues regarding critical government need for flexible biopharmaceutical manufacturing and advanced development of medical countermeasures against bioterror agents and pandemic influenza. Presidents Budget FY2010, all provisions related to BARDA funding via the Public Health and Social Services Emergency Fund, HHS.

LobbyistCovered position, as disclosed
BETH RADA —
PATRICK JEROME SCANNON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.